Cargando…

Development and validation of a novel risk model in newly diagnosed de novo bone metastatic prostate cancer (M1b): a retrospective study

BACKGROUND: Previous studies suggested that bone metastasis has a significant effect on the time of progression to metastatic castration-resistant prostate cancer (CRPC) for newly diagnosed de novo bone metastatic hormone-sensitive prostate cancer (mHSPC). Nevertheless, the effect of different bone...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yang, Wang, Junqi, Ding, Li, Zheng, Yuxin, Wu, Chuang, Wang, Kun, Xia, Wentao, Ge, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2023
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840864/ https://www.ncbi.nlm.nih.gov/pubmed/36650836 http://dx.doi.org/10.7717/peerj.14615

Ejemplares similares

Retrospective validation of bone risk stratification criteria for men with de novo metastatic hormone-naive prostate cancer in China
por: Zhang, Yang, et al.
Publicado: (2023)

Prognostic value of PTEN in de novo diagnosed metastatic prostate cancer
por: Zhang, Jun-Yu, et al.
Publicado: (2021)

Trends in Time Spent Viremic Among Persons Newly Diagnosed With HIV in San Francisco
por: Hughes, Alison J., et al.
Publicado: (2023)

Development of hypotension in patients newly diagnosed with heart failure in UK general practice: retrospective cohort and nested case–control analyses
por: Martín-Pérez, Mar, et al.
Publicado: (2019)

Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990–2010
por: Malmgren, Judith A., et al.
Publicado: (2017)

Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
por: Kaplan, Henry G., et al.
Publicado: (2022)

Prospective associations of depression with survival: a population-based cohort study in patients with newly diagnosed breast cancer
por: Vodermaier, Andrea, et al.
Publicado: (2013)

Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer
por: Yardley, Denise A., et al.
Publicado: (2014)

Effect of eribulin on patients with metastatic breast cancer: multicenter retrospective observational study in Taiwan
por: Rau, Kun-Ming, et al.
Publicado: (2018)

Association Between Time to Antiretroviral Therapy and Loss to Care Among Newly Diagnosed Rwandan People Living with Human Immunodeficiency Virus
por: Murenzi, Gad, et al.
Publicado: (2023)

Prostate cancer with bone metastasis in Beijing: an observational study of prevalence, hospital visits and treatment costs using data from an administrative claims database
por: Zhuo, Lin, et al.
Publicado: (2019)

Increase in newly diagnosed type 1 diabetes in youth during the COVID‐19 pandemic in the United States: A multi‐center analysis
por: Wolf, Risa M., et al.
Publicado: (2022)

A novel prognostic model for Japanese patients with newly diagnosed bone‐metastatic hormone‐naïve prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2020)

When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective study
por: Lin, Yiwei, et al.
Publicado: (2017)

Brief Report: Intimate Partner Violence and Antiretroviral Therapy Initiation Among Female Sex Workers Newly Diagnosed With HIV in Zambia: A Prospective Study
por: Oldenburg, Catherine E., et al.
Publicado: (2018)

A Short-Term Assessment of Nascent HIV-1 Transmission Clusters Among Newly Diagnosed Individuals Using Envelope Sequence-Based Phylogenetic Analyses
por: Kafando, Alexis, et al.
Publicado: (2019)

High Prevalence of Fecal Carriage of Extended Spectrum β-Lactamase-Producing Enterobacteriaceae Among Newly HIV-Diagnosed Adults in a Community Setting in Tanzania
por: Manyahi, Joel, et al.
Publicado: (2020)

The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer
por: Parker, Daniel C., et al.
Publicado: (2020)

Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004–2015
por: Hammond, Edward R, et al.
Publicado: (2021)

Newly Diagnosed Hypokalemic Periodic Paralysis Triggered by COVID-19
por: Schulte, Kelly, et al.
Publicado: (2023)

Using Baidu search index to monitor and predict newly diagnosed cases of HIV/AIDS, syphilis and gonorrhea in China: estimates from a vector autoregressive (VAR) model
por: Huang, Ruonan, et al.
Publicado: (2020)

EPID-11. ESTABLISHING A BASELINE TIME-FRAME FOR SYMPTOM ONSET TO DEFINITIVE DIAGNOSIS FOR CHILDREN WITH NEWLY-DIAGNOSED CNS TUMORS: AN EXPANDED, MULTI-INSTITUTIONAL COLLABORATIVE STUDY
por: Eccles, Eamon, et al.
Publicado: (2020)

Clinical Characteristics and Outcomes of Patients with Newly Diagnosed De Novo Acute Myeloid Leukemia (AML) during the COVID-19 Pandemic
por: Raman, Hari S., et al.
Publicado: (2021)

Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer
por: Lester-Coll, Nataniel H., et al.
Publicado: (2021)

Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score
por: Ebner, Florian, et al.
Publicado: (2023)

Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
por: Ali, Adnan, et al.
Publicado: (2021)

Clinical association between pre-treatment levels of plasma fibrinogen and bone metastatic burden in newly diagnosed prostate cancer patients
por: Xie, Gan-Sheng, et al.
Publicado: (2019)

Bone Metastases Pattern in Newly Diagnosed Metastatic Bladder Cancer: A Population-Based Study
por: Zhang, Chao, et al.
Publicado: (2018)

Validity of self-reported diagnoses of gynaecological and breast cancers in a prospective cohort study: the Japan Nurses’ Health Study
por: Takamatsu, Kiyoshi, et al.
Publicado: (2021)

Prostate cryoablation combined with androgen deprivation therapy for newly diagnosed metastatic prostate cancer: a propensity score-based study
por: wang, Ning, et al.
Publicado: (2021)

Association of triglyceride-glucose index with the risk of prostate cancer: a retrospective study
por: Li, Tianqi, et al.
Publicado: (2023)

Validation of multiple sclerosis diagnoses in the Swedish National Patient Register
por: Murley, Chantelle, et al.
Publicado: (2019)

Medication adherence and glycemic control among newly diagnosed diabetes patients
por: Lin, Lee-Kai, et al.
Publicado: (2017)

Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy
por: Wykoff, Charles C., et al.
Publicado: (2021)

Psychometric evaluation of a newly developed Elderly-Constipation Impact Scale
por: Abdul Wahab, Patimah, et al.
Publicado: (2020)

Preexisting morbidity profile of women newly diagnosed with breast cancer in sub‐Saharan Africa: African Breast Cancer—Disparities in Outcomes study
por: Ayeni, Oluwatosin A., et al.
Publicado: (2020)

Bone Scintigraphy in Staging of Newly Diagnosed Prostate Cancer in Regard of Different Risk Groups
por: Sevcenco, Sabina, et al.
Publicado: (2019)

A narrowing range of bone scan in newly diagnosed prostate cancer patients: A retrospective comparative study
por: Özgür, Berat Cem, et al.
Publicado: (2015)

Predictors of an early death in patients diagnosed with colon cancer: a retrospective case–control study in the UK
por: Donnelly, Conan, et al.
Publicado: (2019)

Prognostic significance of early changes in serum biomarker levels in patients with newly diagnosed metastatic prostate cancer
por: Narita, Shintaro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bplgdmskh7fo9thq2kge45c5cc